Neptune Wellness Solutions (NASDAQ:NEPT) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPTFree Report) (TSE:NTB) in a report released on Monday morning. The brokerage issued a sell rating on the biotechnology company’s stock.

Neptune Wellness Solutions Stock Performance

NEPT opened at $0.44 on Monday. The stock has a market capitalization of $1.99 million, a P/E ratio of 0.00 and a beta of 2.23. The company’s 50-day simple moving average is $0.49 and its two-hundred day simple moving average is $4.14. Neptune Wellness Solutions has a 52-week low of $0.36 and a 52-week high of $28.80.

Neptune Wellness Solutions (NASDAQ:NEPTGet Free Report) (TSE:NTB) last released its quarterly earnings results on Tuesday, November 14th. The biotechnology company reported ($1.38) EPS for the quarter, beating the consensus estimate of ($12.00) by $10.62. The business had revenue of $8.74 million for the quarter. Research analysts forecast that Neptune Wellness Solutions will post -43.2 EPS for the current fiscal year.

Insider Activity

In other news, major shareholder Securities Settlement Neptune sold 215,838 shares of the stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $0.88, for a total transaction of $189,937.44. Following the completion of the transaction, the insider now directly owns 2,128,453 shares in the company, valued at approximately $1,873,038.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last ninety days, insiders sold 450,778 shares of company stock worth $368,645. 5.10% of the stock is currently owned by insiders.

Institutional Trading of Neptune Wellness Solutions

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC increased its stake in Neptune Wellness Solutions by 12.6% in the third quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company’s stock worth $196,000 after purchasing an additional 14,395 shares during the period. Citadel Advisors LLC purchased a new position in shares of Neptune Wellness Solutions during the third quarter valued at $43,000. Stifel Financial Corp purchased a new position in Neptune Wellness Solutions in the first quarter valued at about $41,000. Virtu Financial LLC grew its stake in Neptune Wellness Solutions by 257.6% in the first quarter. Virtu Financial LLC now owns 554,376 shares of the biotechnology company’s stock valued at $123,000 after purchasing an additional 399,362 shares during the last quarter. Finally, Morgan Stanley grew its stake in Neptune Wellness Solutions by 26,898.7% in the fourth quarter. Morgan Stanley now owns 544,833 shares of the biotechnology company’s stock valued at $172,000 after purchasing an additional 542,815 shares during the last quarter. Hedge funds and other institutional investors own 14.44% of the company’s stock.

About Neptune Wellness Solutions

(Get Free Report)

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

See Also

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.